This highlights the need for in-depth research to reveal the role of PD-L2 in evading antitumor immunity in CRC and to elucidate its functional relationship with PD-L1 within the tumor microenvironment. The gene discussed is PDCD1LG2; the disease is colorectal carcinoma.